Share This

PR Newswire Asia's news > Health Care/Hospital

 |   Title only   |   Print    Next page > 
     
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
GAITHERSBURG, Md. , April 18, 2024 /PRNewswire/ -- YS Biopharma Co., Ltd. (Nasdaq: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, ...
2024-04-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
European Wellness Leads Pioneering Down Syndrome Research at Heidelberg University
HEIDELBERG, Germany , April 18, 2024 /PRNewswire/ -- The European Wellness Biomedical Group (EWBG), in collaboration with the European Wellness Academy (EWA), the Baden Research Lab, and Heidelberg ...
2024-04-18T    Health Care/Hospital   Medical/Pharmaceuticals 
FWD Hong Kong employees fuel changes with every step for Weez Walk 2024: Standing strong for youth mental health
HONG KONG , April 18, 2024 /PRNewswire/ -- Weez Walk 2024 ("Weez Walk"), organised by Weez Project and KELY Support Group (collectively "the organisers") and sponsored by FWD Hong ...
2024-04-18T    Banking/Financial Service   Health Care/Hospital   Insurance 
Siriraj Hospital Shines Spotlight on TAVI Procedure as Alternative for High-Risk Patients Requiring Aortic Valve Replacement
BANGKOK , April 18, 2024 /PRNewswire/ -- Siriraj Hospital, a leading healthcare institution in Thailand , stands at the forefront of aortic valve disease treatment with Transcatheter Aortic Valve ...
2024-04-18T    Health Care/Hospital   Medical/Pharmaceuticals 
TaiGen Successfully Completes TG-1000 Phase III Study
TAIPEI , April 18, 2024 /PRNewswire/ -- TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza ...
2024-04-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build "Australia's next CSL"
MELBOURNE, Australia , April 18, 2024 /PRNewswire/ -- Australia's newest biotech incubator Jumar Bioincubator has officially opened its doors and revealed the first 16 innovative early-stage ...
2024-04-18T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Datasea Secures Combined $15 Million with its Second Sales Contract for Acoustic Products
BEIJING , April 17, 2024 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a digital technology company incorporated in Nevada , dedicated to innovative ...
2024-04-17T    Computer Software   Computer/Electronics   Health Care/Hospital   Medical Equipment 
Henlius Releases 2023 ESG Report: Pursuing Sustainable Development with Patient-centricity
SHANGHAI , April 17, 2024 /PRNewswire/ -- On April 17 , 2024, Henlius (2696.HK) released its 2023 Environmental, Social and Governance (ESG) report (hereinafter referred to as "ESG report" ...
2024-04-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
One hundred days to the Games: Transport plan ready
PARIS , April 17, 2024 /PRNewswire/ --  The Île-de- France region and Île-de-France Mobilités, as the leading public financiers, after the Government, have invested more than ...
2024-04-17T    Environmental Products & Services   Green Technology   Health Care/Hospital   High Tech Security 
Clarivate Launches LatAm Market Tracking Solution in Partnership with Global Healthcare Intelligence Enabling Real-Time Tracking of Medical Device Markets
New solution offers comprehensive tracking and analysis of market share and size in Brazil , Colombia , Argentina , Chile , Peru and Ecuador ...
2024-04-17T    Computer/Electronics   Health Care/Hospital 
  Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.